Journal ArticleDOI
Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trial
Martin H. Prins,Luke Bamber,Stefan J. Cano,Maria Y. Wang,Petra M. G. Erkens,Rupert Bauersachs,Anthonie W. A. Lensing +6 more
Reads0
Chats0
TLDR
Rivaroxaban treatment resulted in improved treatment satisfaction compared with enoxaparin/VKA in PE patients, particularly in reducing patient-reported anticoagulation burden.About:
This article is published in Thrombosis Research.The article was published on 2015-02-01. It has received 78 citations till now. The article focuses on the topics: Rivaroxaban & Low molecular weight heparin.read more
Citations
More filters
Journal ArticleDOI
Management of Pulmonary Embolism: An Update.
TL;DR: Campaigns to increase awareness combined with strategies to implement guideline recommendations will be crucial steps towards further optimizing management of acute PE, including the therapeutic implications of subsegmental PE.
Journal ArticleDOI
Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation
Nicolas M. Intagliata,Zachary Henry,Hillary S. Maitland,Neeral L. Shah,Curtis K. Argo,Patrick G. Northup,Stephen H. Caldwell +6 more
TL;DR: This is the first clinical study evaluating the use of direct oral anticoagulant DOAC in patients with cirrhosis, and it is shown that these agents display similar safety characteristics when compared to traditional antICOagulation in Patients with cir rhosis and are potentially attractive agents for anticoAGulation therapy.
Journal ArticleDOI
Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use.
Ida Martinelli,Anthonie W. A. Lensing,Saskia Middeldorp,Marcel Levi,Jan Beyer-Westendorf,Bonno van Bellen,Henri Bounameaux,Timothy A. Brighton,A.T. Cohen,Mila Trajanovic,Martin Gebel,Phuong Lam,Philip S. Wells,Martin H. Prins +13 more
TL;DR: In this article, the authors compared the use of hormonal therapy, especially those containing estrogens, is associated with recurrent venous thromboembolism (VTE) during anticoagulation.
Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use Running head: Recurrent VTE and abnormal uterine bleeding
Ida Martinelli,Saskia Middeldorp,Marcel Levi,Jan Beyer,Bonno van Bellen,Henri Bounameaux,Timothy A. Brighton,Mila Trajanovic,Martin Gebel,Ho Chi Minh +9 more
TL;DR: Hormonal therapy was not associated with an increased risk of recurrent VTE in women receiving therapeutic anticoagulation and the observed increasedrisk of abnormal uterine bleeding with rivaroxaban needs further exploration.
Journal ArticleDOI
Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial
Carsten Weishaupt,Anke Strölin,Birgit Kahle,Alexander Kreuter,Stefan W. Schneider,Joachim Gerss,Maria Eveslage,Attyla Drabik,Tobias Goerge +8 more
TL;DR: It is suggested that rivaroxaban with enoxaparin as a backup treatment is a suitable treatment option for patients with livedoid vasculopathy.
References
More filters
Journal ArticleDOI
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Clive Kearon,Elie A. Akl,Anthony J. Comerota,Paolo Prandoni,Henri Bounameaux,Samuel Z. Goldhaber,Michael E. Nelson,Philip S. Wells,Michael K. Gould,Francesco Dentali,Mark Crowther,Susan R. Kahn +11 more
TL;DR: Strong recommendations apply to most patients, whereas weak recommendations are sensitive to differences among patients, including their preferences.
Journal ArticleDOI
A sharper Bonferroni procedure for multiple tests of significance
TL;DR: In this article, a simple procedure for multiple tests of significance based on individual p-values is derived, which is sharper than Holm's (1979) sequentially rejective procedure.
Journal ArticleDOI
Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)
Adam Torbicki,Arnaud Perrier,Stavros Konstantinides,Giancarlo Agnelli,Nazzareno Galiè,Piotr Pruszczyk,Frank M. Bengel,Adrian J B Brady,Daniel Ferreira,Uwe Janssens,Walter Klepetko,Eckhard Mayer,Martine Remy-Jardin,Jean-Pierre Bassand,Alec Vahanian,John Camm,Raffaele De Caterina,Veronica Dean,Kenneth Dickstein,Gerasimos Filippatos,Christian Funck-Brentano,Irene Hellemans,Steen Dalby Kristensen,Keith McGregor,Udo Sechtem,Sigmund Silber,Michal Tendera,Petr Widimsky,José Luis Zamorano,José Luis Zamorano,Felicita Andreotti,Michael Ascherman,George Athanassopoulos,Johan De Sutter,David Fitzmaurice,Tamás Forster,Magda Heras,Guillaume Jondeau,Keld Kjeldsen,Juhani Knuuti,Irene Lang,Mattie J. Lenzen,Jose Lopez-Sendon,Petros Nihoyannopoulos,Leopoldo Pérez de Isla,Udo Schwehr,Lucia Torraca,Jean-Luc Vachiery +47 more
TL;DR: Non-thrombotic PE does not represent a distinct clinical syndrome but may be due to a variety of embolic materials and result in a wide spectrum of clinical presentations, making the diagnosis difficult.
Journal ArticleDOI
Oral rivaroxaban for symptomatic venous thromboembolism
Rupert Bauersachs,Scott D. Berkowitz,Benjamin Brenner,Harry R. Buller,Hervé Decousus,Alexander Gallus,Anthonie W. A. Lensing,Frank Misselwitz,Martin H. Prins,Gary E. Raskob,Annelise Segers,Peter Verhamme,Phil Wells,Giancarlo Agnelli,Henri Bounameaux,Alexander T. Cohen,Bruce L. Davidson,Franco Piovella,Sebastian Schellong +18 more
TL;DR: Rivaroxaban offers a simple, single-drug approach to the short-term and continued treatment of venous thrombosis that may improve the benefit-to-risk profile of anticoagulation.
Journal ArticleDOI
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.
Marc D. Silverstein,Marc D. Silverstein,John A. Heit,David N. Mohr,Tanya M. Petterson,W. Michael O'Fallon,L. Joseph Melton +6 more
TL;DR: The incidence of pulmonary embolism has decreased over time, the incidence of deep vein thrombosis remains unchanged for men and is increasing for older women, and the need for more accurate identification of patients at risk for venous thromboembolism is emphasized.
Related Papers (5)
Oral rivaroxaban for symptomatic venous thromboembolism
Rupert Bauersachs,Scott D. Berkowitz,Benjamin Brenner,Harry R. Buller,Hervé Decousus,Alexander Gallus,Anthonie W. A. Lensing,Frank Misselwitz,Martin H. Prins,Gary E. Raskob,Annelise Segers,Peter Verhamme,Phil Wells,Giancarlo Agnelli,Henri Bounameaux,Alexander T. Cohen,Bruce L. Davidson,Franco Piovella,Sebastian Schellong +18 more